70 results
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
management, investment research, principal investment, hedging, financing and brokerage activities. The underwriters and certain of their respective
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
, hedging, financing and brokerage activities. The underwriters and certain of their respective affiliates have, from time to time, performed, and may
8-K
EX-10.1
nbo0ki0l184qoo72
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
bnpv q8xk3p
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
661egg i87clvwehga
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
b0nm22 ml5prmtotrb
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm